GEHC · GE HEALTHCARE TECHNOLOGIES INC.

Back to holdings

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products.

Close · 3M

+17.21%

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals5

Win rate40% (2/5)

Avg buy return-0.00%

AIEQno longer held8 signals

AIEQ · Exit · 1d

weight 1.100% → 0 (exited)·stock up 1.0% in the 30 days before

Sep 1·entry $70.42·now $69.72

-0.99%

since Sep 1

AIEQ · Weight decrease · 3d

weight 1.140% → 1.100% (-0.040 pp)·stock up 2.6% in the 30 days before

Aug 30·entry $71.23·now $69.72

-2.12%

since Aug 30

AIEQ · Weight decrease · 2d

weight 1.140% → 1.110% (-0.030 pp)·stock up 2.6% in the 30 days before

Aug 28·entry $71.72·now $69.72

-2.80%

since Aug 28

AIEQ · Weight increase · 2d

weight 1.100% → 1.150% (+0.050 pp)·stock up 20.6% in the 30 days before

Aug 20·entry $74.06·now $69.72Fresh

-5.86%

since Aug 20

AIEQ · Accumulation · 5d

weight 0.050% → 1.100% (+1.050 pp)·stock up 10.9% in the 30 days before

Aug 8·entry $72.94·now $69.72Fresh

-4.41%

since Aug 8

AIEQ · Weight increase · 2d

weight 1.040% → 1.080% (+0.040 pp)·stock up 10.9% in the 30 days before

Aug 7·entry $71.77·now $69.72Fresh

-2.86%

since Aug 7

AIEQ · Sudden change · 1d

weight 0.050% → 1.040% (+0.990 pp)·stock up 4.9% in the 30 days before

Aug 2·entry $69.73·now $69.72

-0.01%

since Aug 2

AIEQ · New entry · 1d

weight 0 → 0.050% (new)·stock up 6.3% in the 30 days before

Jul 1·entry $64.86·now $69.72Drifting

+7.49%

since Jul 1

LQAIno longer held2 signals

LQAI · Exit · 1d

weight 0.240% → 0 (exited)·stock up 1.7% in the 30 days before

Jul 7·entry $64.89·now $69.72

+7.44%

since Jul 7

LQAI · New entry · 1d

weight 0 → 0.250% (new)

Jun 9·entry $66.01·now $69.72Drifting

+5.62%

since Jun 9

AIVLno longer held1 signal

AIVL · Exit · 1d

weight 0.255% → 0 (exited)·stock up 4.5% in the 30 days before

Jul 6·entry $64.84·now $69.72

+7.53%

since Jul 6

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Aug 30

AI ETF AIEQ is showing a recent trend of decreasing its weight in GEHC, indicating a move to reduce exposure to the company. This action aligns with the framework's 'Fail' verdict, as both analyses suggest caution regarding the stock's current investment attractiveness.

Circle of CompetenceThe stable demand for essential medical equipment and established market position suggest predictable unit economics suitable for long-term cash flow projections.
Economic MoatGE Healthcare benefits from high switching costs, strong brand reputation, scale advantages in manufacturing and R&D, and significant regulatory barriers to entry.
ManagementThe provided financial data does not offer sufficient information to assess management's candor, capital allocation discipline, or skin in the game.
Financial HealthWhile the reported single-year ROE is strong, the absence of 10-year ROE, operating margin trends, detailed debt information, and owner earnings prevents a comprehensive assessment of financial health.
Margin of SafetyWithout a conservative estimate of intrinsic value, it is not possible to confirm a defensible margin of safety, and the high EV/EBITDA ratio suggests a potentially high valuation.

While GE Healthcare Technologies operates within a clear circle of competence and possesses strong economic moats, a thorough financial health assessment is constrained by insufficient historical data on key metrics such as 10-year ROE and owner earnings. Additionally, without a clear intrinsic value estimate, a margin of safety cannot be confidently identified, especially given the company's current EV/EBITDA ratio, leading to an overall 'Fail' verdict within this framework.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.